Published in Cancer Res on March 01, 2002
p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol (2003) 2.97
miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle (2010) 2.63
Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev RNA (2010) 2.59
ARED 2.0: an update of AU-rich element mRNA database. Nucleic Acids Res (2003) 2.39
The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res (2009) 1.88
Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes (2010) 1.80
Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol Cell Biol (2006) 1.77
Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res (2005) 1.69
Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J Exp Med (2003) 1.58
Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol Life Sci (2010) 1.58
The role of AUF1 in regulated mRNA decay. Wiley Interdiscip Rev RNA (2011) 1.34
Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state. Cell (2012) 1.29
Identification of a signature motif in target mRNAs of RNA-binding protein AUF1. Nucleic Acids Res (2008) 1.25
Increased stability of the p16 mRNA with replicative senescence. EMBO Rep (2005) 1.24
Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation. Biochim Biophys Acta (2012) 1.16
Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach. Cancer Res (2008) 1.11
Role of CSF-1 in progression of epithelial ovarian cancer. Future Oncol (2009) 1.07
Modulation of neoplastic gene regulatory pathways by the RNA-binding factor AUF1. Front Biosci (Landmark Ed) (2011) 1.06
HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. Gastroenterology (2010) 1.04
AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein-Barr virus. RNA (2012) 1.02
RNA-binding protein AUF1 represses Dicer expression. Nucleic Acids Res (2012) 0.96
MicroRNA-141 and microRNA-146b-5p inhibit the prometastatic mesenchymal characteristics through the RNA-binding protein AUF1 targeting the transcription factor ZEB1 and the protein kinase AKT. J Biol Chem (2014) 0.96
Cia5d regulates a new fibroblast-like synoviocyte invasion-associated gene expression signature. Arthritis Res Ther (2008) 0.95
Impaired gametogenesis in mice that overexpress the RNA-binding protein HuR. EMBO Rep (2003) 0.95
Temporally regulated traffic of HuR and its associated ARE-containing mRNAs from the chromatoid body to polysomes during mouse spermatogenesis. PLoS One (2009) 0.93
Impaired embryonic development in mice overexpressing the RNA-binding protein TIAR. PLoS One (2010) 0.92
AUF1 cell cycle variations define genomic DNA methylation by regulation of DNMT1 mRNA stability. Mol Cell Biol (2006) 0.90
The RNA-binding protein ELAVL1/HuR is essential for mouse spermatogenesis, acting both at meiotic and postmeiotic stages. Mol Biol Cell (2011) 0.88
AUF1 and HuR: possible implications of mRNA stability in thyroid function and disorders. Thyroid Res (2011) 0.85
The cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1. J Biol Chem (2014) 0.85
Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ. Oncogene (2014) 0.83
Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs. Nucleic Acids Res (2013) 0.83
Reduction of AUF1-mediated follistatin mRNA decay during glucose starvation protects cells from apoptosis. Nucleic Acids Res (2014) 0.80
Hallmarks of cancer and AU-rich elements. Wiley Interdiscip Rev RNA (2016) 0.78
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth. J Clin Invest (2015) 0.78
Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis. Int J Mol Sci (2016) 0.77
Can we observe changes in mRNA "state"? Overview of methods to study mRNA interactions with regulatory proteins relevant in cancer related processes. Analyst (2016) 0.77
Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer. J Transl Med (2015) 0.76
Induction of epithelial-mesenchymal transition (EMT) by Beclin 1 knockdown via posttranscriptional upregulation of ZEB1 in thyroid cancer cells. Oncotarget (2016) 0.75
AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding protein. Mech Dev (2015) 0.75
The superoxide dismutase 1 3'UTR maintains high expression of the SOD1 gene in cancer cells: The involvement of the RNA-binding protein AUF-1. Free Radic Biol Med (2015) 0.75
Genome-wide identification of Wig-1 mRNA targets by RIP-Seq analysis. Oncotarget (2016) 0.75
Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med (2008) 2.49
ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood (2003) 2.05
Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol (2012) 1.85
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood (2006) 1.65
The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene. Oncogene (2005) 1.64
Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis. J Clin Oncol (2009) 1.64
Human herpesvirus-8-associated lymphoma of the bowel in human immunodeficiency virus-positive patients without history of primary effusion lymphoma. Hum Pathol (2002) 1.49
An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol (2004) 1.46
Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells. Oncogene (2004) 1.35
Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. Cancer Res (2002) 1.27
Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol (2005) 1.25
Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study. Blood (2007) 1.23
Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Blood (2003) 1.22
Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol Cell Biol (2006) 1.19
Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation. J Exp Med (2005) 1.18
Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J Clin Oncol (2011) 1.16
MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood (2011) 1.14
Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma. Genes Chromosomes Cancer (2003) 1.13
A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5. Blood (2006) 1.11
Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials. J Clin Oncol (2012) 1.07
AU-rich elements regulate Drosophila gene expression. Mol Cell Biol (2009) 1.05
A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK. Blood (2006) 1.02
TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins. Eur J Cancer (2007) 1.02
Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood (2003) 1.01
Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol (2008) 1.01
Acquisition of viral receptor by NK cells through immunological synapse. J Immunol (2003) 1.01
Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy. Cancer Biol Ther (2007) 1.00
The Th2 lymphoproliferation developing in LatY136F mutant mice triggers polyclonal B cell activation and systemic autoimmunity. J Immunol (2006) 0.99
Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases. Haematologica (2009) 0.99
Isolation of differentially expressed genes in NPM-ALK-positive anaplastic large cell lymphoma. Br J Haematol (2002) 0.97
HuR-mediated control of C/EBPbeta mRNA stability and translation in ALK-positive anaplastic large cell lymphomas. Mol Cancer Res (2011) 0.97
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. Haematologica (2013) 0.96
Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation. J Virol (2002) 0.96
A high inorganic phosphate diet perturbs brain growth, alters Akt-ERK signaling, and results in changes in cap-dependent translation. Toxicol Sci (2005) 0.96
Impaired gametogenesis in mice that overexpress the RNA-binding protein HuR. EMBO Rep (2003) 0.95
Intrasinusoidal bone marrow infiltration: a common growth pattern for different lymphoma subtypes. Br J Haematol (2002) 0.94
SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling. Blood (2006) 0.94
Temporally regulated traffic of HuR and its associated ARE-containing mRNAs from the chromatoid body to polysomes during mouse spermatogenesis. PLoS One (2009) 0.93
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med (2011) 0.92
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood (2006) 0.92
Impaired embryonic development in mice overexpressing the RNA-binding protein TIAR. PLoS One (2010) 0.92
Extended surveillance for CBPP in a free country: Challenges and solutions regarding the potential caprine reservoir. Prev Vet Med (2011) 0.90
Expression patterns of the coe/ebf transcription factor genes during chicken and mouse limb development. Gene Expr Patterns (2004) 0.89
Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. Am J Pathol (2003) 0.89
Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samples. Br J Haematol (2003) 0.89
The RNA-binding protein ELAVL1/HuR is essential for mouse spermatogenesis, acting both at meiotic and postmeiotic stages. Mol Biol Cell (2011) 0.88
STAT6 deletion converts the Th2 inflammatory pathology afflicting Lat(Y136F) mice into a lymphoproliferative disorder involving Th1 and CD8 effector T cells. J Immunol (2009) 0.88
Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers. Proteomics (2006) 0.86
Interplay between chromatin-modifying enzymes controls colon cancer progression through Wnt signaling. Hum Mol Genet (2013) 0.86
ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases. Am J Surg Pathol (2006) 0.85
RNA-binding proteins, RNA granules, and gametes: is unity strength? Reproduction (2011) 0.84
Human herpesvirus 8 infections in patients with immunodeficiencies. Hum Pathol (2008) 0.84
PNL2, a new monoclonal antibody directed against a fixative-resistant melanocyte antigen. Mod Pathol (2003) 0.83
Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia. Blood (2010) 0.83
Stabilization of Dll1 mRNA by Elavl1/HuR in neuroepithelial cells undergoing mitosis. Mol Biol Cell (2011) 0.83
Effect of an inactivated paratuberculosis vaccine on the intradermal testing of goats for tuberculosis. Vet J (2011) 0.82
Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway. Cancer Res (2009) 0.82
Modulo is a target of Myc selectively required for growth of proliferative cells in Drosophila. Mech Dev (2003) 0.82
Low dietary inorganic phosphate affects the brain by controlling apoptosis, cell cycle and protein translation. J Nutr Biochem (2007) 0.82
Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes. Haematologica (2009) 0.81
Anaplastic lymphoma kinase as a therapeutic target. Expert Opin Ther Targets (2012) 0.80
ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation. Blood (2012) 0.80
Characterisation of Mycoplasma capricolum P60 surface lipoprotein and its evaluation in a recombinant ELISA. Vet Microbiol (2007) 0.80
Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus. J Virol (2002) 0.79
ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood (2008) 0.79
Follicular dendritic cell tumor of the spleen associated with diffuse large B-cell lymphoma. Hum Pathol (2008) 0.79
Characterization of bone marrow lymphoid infiltrates after immunochemotherapy for follicular lymphoma. Am J Clin Pathol (2007) 0.79
CD4+ T cells downregulate Bcl-2 in germinal centers. J Clin Immunol (2005) 0.79
Single-cell analysis of loss of heterozygosity at the ATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma: ATM loss of heterozygosity is a rare event. Int J Cancer (2005) 0.79
Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease. Br J Haematol (2003) 0.79
zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia. FASEB J (2010) 0.79
Evidence of finely tuned expression of DNA polymerase beta in vivo using transgenic mice. FEBS Lett (2004) 0.79
In Hodgkin's disease Reed-Sternberg cells and normal B-lymphocytes are infected by related Epstein-Barr virus strains. Virus Res (2004) 0.78
Serological evidence of caprine herpesvirus 1 infection in Mediterranean France. Vet Microbiol (2007) 0.78
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth. J Clin Invest (2015) 0.78
Gene expression profiling in anaplastic large cell lymphoma and Hodgkin's disease. Leuk Lymphoma (2004) 0.78
A new mitotic-cell specific monoclonal antibody. Cell Cycle (2007) 0.78
[Aberrant regulation of mRNA 3' untranslated region in cancers and inflammation]. Med Sci (Paris) (2008) 0.78
Clustering and anticipation for nodular lymphocyte predominance Hodgkin lymphoma within a French Basque kindred. Br J Haematol (2005) 0.78
Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase. Anticancer Drugs (2009) 0.77
Looking for the functions of RNA granules in ALK-transformed cells. Bioarchitecture (2011) 0.77
Novel mRNA-containing cytoplasmic granules in ALK-transformed cells. Mol Biol Cell (2011) 0.77